Pharmaceuticals, Biotechnology and Life Sciences
Phase 3 RAISE trial interim analysis enrollment target achieved with Data Monitoring Committee (DMC) review scheduled and topline results expected…
DUBLIN–(BUSINESS WIRE)–The “Impact of the InVitro Diagnostic Regulation (IVDR) on the Conduct of Clinical Trials in the EU and CRO…
PHOENIX–(BUSINESS WIRE)–Statistics & Data Corporation (SDC), a global leader in life sciences biometrics services and technology solutions, announces a strategic…
MANHASSET, N.Y.–(BUSINESS WIRE)–Approximately 352,000 Americans under the age of 20 have type 1 diabetes, and every year 64,000 Americans more…
CytoTronics honored for the North American debut of Pixel; opens enrollment for early access program. BOSTON–(BUSINESS WIRE)–CytoTronics, Inc., a pioneer…
Scott to Transition to Executive Board Chair GEORGETOWN, Texas–(BUSINESS WIRE)–AustinPx, developers of the next generation amorphous dispersion platform, KinetiSol™ Technology,…
MENLO PARK, Calif.–(BUSINESS WIRE)–Grace Science, LLC announced today that the first patient was dosed in an open-label Phase 1/2/3 clinical…
BALTIMORE–(BUSINESS WIRE)–$MYMD–MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company committed to developing novel therapies…
The fastest growing global index provider has licensed its Morningstar US Healthcare Index to IMX Health, the first financial futures…
TORONTO–(BUSINESS WIRE)–Novel Bio, a leader in next-generation biomanufacturing technologies for plasmid DNA for use in genetic medicines, announced today that…